Terms: = Thyroid cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST
87 results:
1. Evaluation of the Therapeutic Effects of Harmine on Anaplastic thyroid cancer Cells.
Baldini E; Cardarelli S; Campese AF; Lori E; Fallahi P; Virili C; Forte F; Pironi D; Di Matteo FM; Palumbo P; Costanzo ML; D'Andrea V; Centanni M; Sorrenti S; Antonelli A; Ulisse S
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256193
[TBL] [Abstract] [Full Text] [Related]
2. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve thyroid cancer with Aggressive Behavior.
Revilla G; Al Qtaish N; Caruana P; Sainz-Ramos M; Lopez-Mendez T; Rodriguez F; Paez-Espinosa V; Li C; Vallverdú NF; Edwards M; Moral A; Pérez JI; Escolà-Gil JC; Pedraz JL; Gallego I; Corcoy R; Céspedes MV; Puras G; Mato E
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002329
[TBL] [Abstract] [Full Text] [Related]
3. The importance of sentinel lymph node diagnostic biopsy from the lateral neck compartment in the surgical treatment of papillary thyroid cance.
Arciniegas LM; Reken V; Nemergut S; Sabol M; Durdik S; Kralik R
Bratisl Lek Listy; 2023; 124(11):827-832. PubMed ID: 37874805
[TBL] [Abstract] [Full Text] [Related]
4. Using CRISPR/Cas9 to Edit a thyroid cancer Cell Line.
Fuziwara CS; Kimura ET
Adv Exp Med Biol; 2023; 1429():73-84. PubMed ID: 37486517
[TBL] [Abstract] [Full Text] [Related]
5. Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in cancer Cells.
Zwergel C; Aventaggiato M; Garbo S; Di Bello E; Fassari B; Noce B; Castiello C; Lambona C; Barreca F; Rotili D; Fioravanti R; Schmalz T; Weyand M; Niedermeier A; Tripodi M; Colotti G; Steegborn C; Battistelli C; Tafani M; Valente S; Mai A
J Med Chem; 2023 Jul; 66(14):9622-9641. PubMed ID: 37439550
[TBL] [Abstract] [Full Text] [Related]
6. Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in cal-62 and BHT-101 Anaplastic thyroid Carcinoma Cell Lines.
Shi XZ; Zhao S; Wang Y; Wang MY; Su SW; Wu YZ; Xiong C
Drug Des Devel Ther; 2023; 17():1889-1906. PubMed ID: 37397788
[TBL] [Abstract] [Full Text] [Related]
7. Extra-Cellular Vesicles Derived from thyroid cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms.
Mardente S; Aventaggiato M; Splendiani E; Mari E; Zicari A; Catanzaro G; Po A; Coppola L; Tafani M
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769076
[TBL] [Abstract] [Full Text] [Related]
8. Influence of autoimmune thyroiditis on the prognosis of papillary thyroid carcinoma.
Grigerova M; Kasko M; Mojtova E; Takacsova E; Kralik R; Waczulikova I; Podoba J
Bratisl Lek Listy; 2022; 123(12):885-890. PubMed ID: 36342875
[TBL] [Abstract] [Full Text] [Related]
9. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract] [Full Text] [Related]
10. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer.
Yi D; Yilihamu Y; Jiang C; Wang R; Lu X; Sang J; Su L
Tissue Cell; 2022 Aug; 77():101869. PubMed ID: 35870426
[TBL] [Abstract] [Full Text] [Related]
11. Case 306.
Mamone G; Caruso S; Milazzo M; Miraglia R
Radiology; 2022 Jun; 303(3):722-725. PubMed ID: 35604842
[TBL] [Abstract] [Full Text] [Related]
12. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
Gao H; Wang W; Li Q
Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
[TBL] [Abstract] [Full Text] [Related]
13. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
14. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract] [Full Text] [Related]
15. [The mechanism of circ_0023990/miR-873-5p/ANXA2 axis regulating radiosensitivity and development of thyroid carcinoma].
Li HG; Zhao LH; Lu A; Liu JB; Su ZJ; Wang XB; Gao YJ
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3329-3337. PubMed ID: 34758534
[No Abstract] [Full Text] [Related]
16. Inactivation of PDH can Reduce Anaplastic thyroid cancer Cells' Sensitivity to Artemisinin.
Li Y
Anticancer Agents Med Chem; 2022; 22(9):1753-1760. PubMed ID: 34515013
[TBL] [Abstract] [Full Text] [Related]
17. miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase.
Liu Z; Zhang L; Chen W; Yuan F; Yang Z; Liu S; Le F
Bioengineered; 2021 Dec; 12(1):6201-6209. PubMed ID: 34482792
[TBL] [Abstract] [Full Text] [Related]
18. Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells.
Li R; Li W; He F; Zhang M; Luo H; Tang H
J Oral Pathol Med; 2021 Oct; 50(9):882-890. PubMed ID: 34358353
[TBL] [Abstract] [Full Text] [Related]
19. A 44-Year-Old Woman With Multiple Neoplasms and Cystic Lung Disease.
Moguillansky N; Ataya A
Chest; 2021 Jun; 159(6):e381-e384. PubMed ID: 34099154
[TBL] [Abstract] [Full Text] [Related]
20. New Treatment Strategy Targeting Galectin-1 against thyroid cancer.
Gheysen L; Soumoy L; Trelcat A; Verset L; Journe F; Saussez S
Cells; 2021 May; 10(5):. PubMed ID: 34063063
[TBL] [Abstract] [Full Text] [Related]
[Next]
